Research output per year
Research output per year
Personal profile
Research interests
-
Focus on interdisciplinary, translational cardiovascular research in the ageing/ diabetic patient.
-
Atherosclerosis imaging in the ageing population: a translational approach.
-
Imaging of cell death in cardiovascular disease and oncology
Education/Academic qualification
Annexin A5: pharmacology, radiopharmaceutical aspects and cell death imaging, Maastricht University
1-Jan-1999 → 30-Apr-2006
Award Date: 6-Apr-2006
Clinical Pharmacology certification, AZM, Clinical Pharmacy and Toxicology
31-Jan-2001 → 1-Feb-2003
Award Date: 11-Apr-2003
PharmD, RUG
1-Sept-1988 → 29-Aug-1996
Award Date: 29-Aug-1996
External positions
Hospital Pharmacist, AZM, Clinical Pharmacy and Toxicology
30-Nov-2001 → 1-Jun-2007
Pharmacist, AZM, Clinical Pharmacy an Toxicology
1-Jan-1998 → 1-Nov-2000
AZM , Department of Nuclear Medicine, Maastricht Academic Hospital, Maastricht, The Netherlands
1-Jan-1998 → 1-Jun-2007
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 2 Zero Hunger -
SDG 3 Good Health and Well-being -
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
Dive into the research topics where Hendrikus Boersma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
50 Years of postmortem redistribution research: What have we learned?
Borra, L. C. P., van der Hulst, R., Elsinga, P. H., Boersma, H. H., Bosman, I. J. & Touw, D. J., Feb-2026, In: Forensic Science International. 378, 9 p., 112699.Research output: Contribution to journal › Review article › peer-review
Open AccessFile -
Cost-effectiveness of [¹¹C]Choline PET/CT as first-line imaging in primary hyperparathyroidism
Schouw, H. M., Melis, J., Lutterop, J. W., Boersma, H. H., Noltes, M. E., van der Hilst, C. S., Bonnema, M. I., Appelman, A. P. A., Zandee, W. T., Kruijff, S., Vermeulen, K. M. & Brouwers, A. H., 9-Feb-2026, In: European Journal of Nuclear Medicine and Molecular Imaging. 53, p. 4186–4198 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Intraoperative fluorescence-guided fresh frozen sectioning for margin control in head and neck cancer: phase 2 clinical trial
Nijboer, T. S., Keizers, B., Boeve, K., Roos, D., de Visscher, S. A. H. J., Halmos, G. B., Plaat, B. E. C., Huizinga, H. K., Boersma, H. H., Doff, J. J., Schepman, K.-P., van der Vegt, B., Witjes, M. J. H. & Voskuil, F. J., 24-Apr-2026, In: Nature Communications. 17, 9 p., 3769.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
[68Ga]FAPI PET/CT reveals increased pulmonary fibroblast activation protein expression in long COVID patients after ICU discharge.
COVID CLIMATE Consortium, van Leer, B., Londema, M., Kasalak, Ö., van Snick, J. H., Duiverman, M. L., Kuijvenhoven, J. C., de Kruif, M. D., Oprea-Lager, D. E., Pabst, K., Hellemons, M. E., Boersma, H. H., Prokop, M., Nijsten, M. W., Glaudemans, A. W. J. M., Pillay, J. & Slart, R. H. J. A., Dec-2025, In: European Journal of Nuclear Medicine and Molecular Imaging. 53, p. 565-573 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Extemporaneous Compounding, Pharmacy Preparations and Related Product Care in the Netherlands
Woerdenbag, H. J., van Basten, B., Oussoren, C., Smeets, O. S. N. M., Annaciri-Donkers, A., Crul, M., Maurer, J. M., Schimmel, K. J. M., Kemper, E. M., Hooge, M. N.L.-D., Schreuder, N., Eikmann, M., Ramcharan, A. S., Lantink, R. B., Quodbach, J., Boersma, H. H., Kelder, O., Larmené-Beld, K. H. M., Le Brun, P. P. H. & Kok, R. J. & 4 others, , 31-Jul-2025, In: Pharmaceutics. 17, 8, 48 p., 1005.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile
Activities
-
Inflammatory fluorescent imaging (working title)
Boersma, H. (Co-supervisor)
2026 → 2028Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
International Journal of Clinical Pharmacy (Journal)
Boersma, H. (Peer reviewer)
2025Activity: Peer-review and editorial work › Peer-review › Professional
-
-
Molecular imaging (Journal)
Boersma, H. (Peer reviewer)
2025Activity: Peer-review and editorial work › Peer-review › Professional
-
EMIM European Society of Molecular Imaging (External organisation)
Boersma, H. (Member)
2025Activity: Membership › Professional
Press/Media
-
Verzekerd van uitsluiting - goede voorlichting over risico's kan proefpersonen duur komen te staan
21/01/2025
1 Media contribution
Press/Media: Expert Comment › Professional
-
Annexin rapporterar de första resultaten i imaging-studien av retinal venocklusion
18/04/2023
2 items of Media coverage, 1 Media contribution
Press/Media: Expert Comment › Popular
-
Annexin Pharmaceuticals AB: Annexin reports first imaging-study results in Retinal Vein Occlusion
18/04/2023
1 item of Media coverage, 1 Media contribution
Press/Media: Expert Comment › Popular
-
NIR Fluorescence Molecular Imaging of ANXV-800CW in RVO Patients (SIGHT)
24/11/2021
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Interview with Go van Dam and Hendrikus Boersma on a novel Phase I study
06/04/2021
1 Media contribution
Press/Media: Public Engagement Activities › Academic
Prizes
-
Member of the Woldring Committee
Boersma, H. (Recipient), 15-Dec-2025
Prize: Election to learned society › Academic
File -
CHASE STUDY - Study on imaging using 89Zr-APAC in patients (€ 152,600 funding in person)
Boersma, H. (Recipient), 1-Oct-2024
Prize › Academic
File -
The Vartutrace study (€ 40,000 funding in person)
Boersma, H. (Recipient), 15-Oct-2024
Prize › Academic
File -
-